PMID- 34303707 OWN - NLM STAT- MEDLINE DCOM- 20211203 LR - 20211214 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 297 IP - 2 DP - 2021 Aug TI - Metformin inhibits MAPK signaling and rescues pancreatic aquaporin 7 expression to induce insulin secretion in type 2 diabetes mellitus. PG - 101002 LID - S0021-9258(21)00804-8 [pii] LID - 10.1016/j.jbc.2021.101002 [doi] LID - 101002 AB - Metformin is the first-line antidiabetic agent for type 2 diabetes mellitus (T2DM) treatment. Although accumulated evidence has shed light on the consequences of metformin action, the precise mechanisms of its action, especially in the pancreas, are not fully understood. Aquaporin 7 (AQP7) acts as a critical regulator of intraislet glycerol content, which is necessary for insulin production and secretion. The aim of this study was to investigate the effects of different doses of metformin on AQP7 expression and explore the possible mechanism of its protective effects in the pancreatic islets. We used an in vivo model of high-fat diet in streptozocin-induced diabetic rats and an in vitro model of rat pancreatic beta-cells (INS-1 cells) damaged by hyperglycemia and hyperlipidemia. Our data showed that AQP7 expression levels were decreased, whereas p38 and JNK mitogen-activated protein kinases (MAPKs) were activated in vivo and in vitro in response to hyperglycemia and hyperlipidemia. T2DM rats treated with metformin demonstrated a reduction in blood glucose levels and increased regeneration of pancreatic beta-cells. In addition, metformin upregulated AQP7 expression as well as inhibited activation of p38 and JNK MAPKs both in vivo and in vitro. Overexpression of AQP7 increased glycerol influx into INS-1 cells, whereas inhibition of AQP7 reduced glycerol influx, thereby decreasing subsequent insulin secretion. Our findings demonstrate a new mechanism by which metformin suppresses the p38 and JNK pathways, thereby upregulating pancreatic AQP7 expression and promoting glycerol influx into pancreatic beta-cells and subsequent insulin secretion in T2DM. CI - Copyright (c) 2021 The Authors. Published by Elsevier Inc. All rights reserved. FAU - He, Xueting AU - He X AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Gao, Fei AU - Gao F AD - Department of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Hou, Jiaojiao AU - Hou J AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Li, Tingjie AU - Li T AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Tan, Jiang AU - Tan J AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Wang, Chunyu AU - Wang C AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Liu, Xiaoyan AU - Liu X AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Wang, Maoqi AU - Wang M AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Liu, Hui AU - Liu H AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Chen, Yuqin AU - Chen Y AD - Institute of Neuroscience, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Yu, Zhuoyuan AU - Yu Z AD - Department of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China. FAU - Yang, Mei AU - Yang M AD - Department of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. Electronic address: yangmei503@cqmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210722 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Aqp7 protein, rat) RN - 0 (Aquaporins) RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) RN - 9100L32L2N (Metformin) SB - IM MH - Animals MH - Aquaporins/genetics/*metabolism MH - Cells, Cultured MH - Diabetes Mellitus, Experimental/*drug therapy/metabolism/pathology MH - Diabetes Mellitus, Type 2/*drug therapy/metabolism/pathology MH - Disease Models, Animal MH - Hypoglycemic Agents/pharmacology MH - Insulin/*metabolism MH - Insulin-Secreting Cells/drug effects/*metabolism MH - MAP Kinase Signaling System/*drug effects MH - Male MH - Metformin/*pharmacology MH - Rats PMC - PMC8374641 OTO - NOTNLM OT - MAPK OT - aquaporin 7 (AQP7) OT - diabetes OT - metformin OT - pancreas COIS- Conflict of interest The authors declare that they have no conflict of interest associated with this study. EDAT- 2021/07/26 06:00 MHDA- 2021/12/15 06:00 PMCR- 2021/07/22 CRDT- 2021/07/25 20:29 PHST- 2021/01/19 00:00 [received] PHST- 2021/07/15 00:00 [revised] PHST- 2021/07/21 00:00 [accepted] PHST- 2021/07/26 06:00 [pubmed] PHST- 2021/12/15 06:00 [medline] PHST- 2021/07/25 20:29 [entrez] PHST- 2021/07/22 00:00 [pmc-release] AID - S0021-9258(21)00804-8 [pii] AID - 101002 [pii] AID - 10.1016/j.jbc.2021.101002 [doi] PST - ppublish SO - J Biol Chem. 2021 Aug;297(2):101002. doi: 10.1016/j.jbc.2021.101002. Epub 2021 Jul 22.